SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-153295
Filing Date
2021-05-06
Accepted
2021-05-06 16:16:10
Documents
14
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d183392d8k.htm   iXBRL 8-K 22344
2 EX-99.1 d183392dex991.htm EX-99.1 31423
6 GRAPHIC g183392777g23h05.jpg GRAPHIC 4257
  Complete submission text file 0001193125-21-153295.txt   178452

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ck0001496671-20210506.xsd EX-101.SCH 3117
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001496671-20210506_lab.xml EX-101.LAB 16083
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001496671-20210506_pre.xml EX-101.PRE 10144
7 EXTRACTED XBRL INSTANCE DOCUMENT d183392d8k_htm.xml XML 3041
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36644 | Film No.: 21897990
SIC: 2834 Pharmaceutical Preparations